Work

Abstract PS3-01-28: Effects of 6 Months of Tirzepatide on Risk Biomarkers for Development of Breast Cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-01-28

Authors: C. J. Fabian, C. R. Beaver, K. R. Powers, L. Ranallo, A. L. Kreutzjans, K. Pittman, C. Altman, T. Metheny, R. Biswell, A. Zelenchuk, H. Pathak, A. Mitra, A. K. Godwin, D. P. Mudaranthakam, E. D. Giles, S. D. Hursting, K. L. Cook, B. F. Kimler

Institutions: University of Kansas Medical Center, University of Michigan, University of North Carolina at Chapel Hill, Wake Forest University Health Sciences, Wake Forest University

Language: English

Topic: Cancer Risks and Factors

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129568672

Cites:

Cited by:

Related to: